Indian Journal of Ophthalmology (Indian J Ophthalmol)

Publisher: All India Ophthalmological Society, Medknow Publications

Journal description

The Indian Journal of Ophthalmology or IJO which is in its 53rd year today, is the official scientific journal of the All India Ophthalmological Society (AIOS), which at a membership strength of over 9000 is probably the 2nd largest society of ophthalmologists in the world. The IJO which is an indexed, peer reviewed journal, originated as a platform for the scientific expression of the AIOS which is the umbrella society to which almost all ophthalmologists in India belong. However it has grown over the years to be international in its scope, also accepting articles of merit from contributors all over the world. IJO is published 4 times a year in March, June, September, and December.

Current impact factor: 0.90

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 0.9
2013 Impact Factor 0.927
2011 Impact Factor 1.019
2010 Impact Factor 0.827

Impact factor over time

Impact factor

Additional details

5-year impact 0.98
Cited half-life 5.90
Immediacy index 0.19
Eigenfactor 0.00
Article influence 0.25
Website Indian Journal of Ophthalmology website
Other titles Indian journal of ophthalmology (Online)
ISSN 0301-4738
OCLC 60352341
Material type Periodical, Internet resource
Document type Internet Resource, Journal / Magazine / Newspaper

Publisher details

Medknow Publications

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Non-commercial
    • Publisher's version/PDF may be used
    • Creative Commons Attribution Non-Commercial Share Alike License
    • Published source must be acknowledged
    • All titles are open access journals
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine if providing high dose anti-oxidant vitamins and zinc treatment age-related eye disease study (AREDS formulation) to patients with intermediate age-related macular degeneration (AMD) aged 40-79 years from Singapore is cost-effective in preventing progression to wet AMD. A hypothetical cohort of category 3 and 4 AMD patients from Singapore was followed for 5 calendar years to determine the number of patients who would progress to wet AMD given the following treatment scenarios: (a) AREDS formulation or placebo followed by ranibizumab (as needed) for wet AMD. (b) AREDS formulation or placebo followed by bevacizumab (monthly) for wet AMD. (c) AREDS formulation or placebo followed by aflibercept (VIEW I and II trial treatment regimen). Costs were estimated for the above scenarios from the providers' perspective, and cost-effectiveness was measured by cost per disability-adjusted life year (DALY) averted with a disability weight of 0.22 for wet AMD. The costs were discounted at an annual rate of 3%. Over 5400 patients could be prevented from progressing to wet AMD cumulatively if AREDS formulation were prescribed. AREDS formulation followed by ranibizumab was cost-effective compared to placebo-ranibizumab or placebo-aflibercept combinations (cost per DALY averted: SGD$23,662.3 and SGD$21,138.8, respectively). However, bevacizumab (monthly injections) alone was more cost-effective compared to AREDS formulation followed by bevacizumab. Prophylactic treatment with AREDS formulation for intermediate AMD patients followed by ranibizumab or for patients who progressed to wet AMD was found to be cost-effective. These findings have implications for intermediate AMD screening, treatment and healthcare planning in Singapore.
    Indian Journal of Ophthalmology 06/2015; DOI:10.4103/0301-4738.158533
  • Indian Journal of Ophthalmology 04/2015; 63(4):361. DOI:10.4103/0301-4738.158108
  • Indian Journal of Ophthalmology 03/2015; 63(3):287-288.
  • Indian Journal of Ophthalmology 01/2015; 63(3):287. DOI:10.4103/0301-4738.156948
  • Indian Journal of Ophthalmology 01/2015; 63(3):289. DOI:10.4103/0301-4738.156956
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of a 2-month-old baby with bilateral nonsyndromic partial cryptophthalmos presenting with upper eyelid incomplete development and fusion to the cornea with resultant inability to close the eyes. He was managed successfully with bilateral upper lid reconstruction with composite graft using maternal skin and oral mucous membrane, amniotic membrane, and donor scleral graft. After this one stage surgery, lids were well-formed, and the patient was able to close both eyes, thus achieving good anatomical, functional, and cosmetic outcome.
    Indian Journal of Ophthalmology 11/2014; 11(62):1096. DOI:10.4103/0301-4738.146754.
  • Indian Journal of Ophthalmology 10/2014; 62(10):1025-1027. DOI:10.4103/0301-4738.146019
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aims: To study the relationship between blood pressure (BP), intraocular pressure (IOP), mean ocular perfusion pressure (MOPP) and primary open angle glaucoma (POAG) in patients with hypertension and compare it to a control group of normotensives. Design: Cross-sectional observational study. Materials and Methods: A total of 108 subjects with primary hypertension and 100 age-matched controls without hypertension were enrolled for the study. IOP measurement using Noncontact Tonometer and dilated fundus evaluation using + 90 D lens were done for all cases. Single recording of BP was taken. Gonioscopy, Humphrey's central visual fields, optical coherence tomography and pachymetry were done for all subjects with IOP >21 mm Hg or C: D ratio >= 0.5 or asymmetry of > 0.2. Statistical Analysis: Univariate and multivariate multinomial regression models were used to determine the association between covariates and risk of glaucoma or glaucoma suspect. Results: There was no difference in the glaucoma status between subjects with and without hypertension. Subjects on antihypertensive medications were 1 1/2 times more likely to have suspicious glaucoma (odds ratio [OR] = 1.56] and nearly twice as likely to have POAG (OR = 1.85). In addition, we found a 31% and 12% reduction in risk of having POAG (95% confidence interval [CI] = 13-45%, P = 0.001) and glaucoma suspect (95% CI = 2-21%, P = 0.03) respectively with every 1 mm Hg increment in MOPP. Conclusion: Subjects on antihypertensive medications are more likely to have either glaucoma or glaucoma suspect, and higher ocular perfusion pressure offers relative protection from glaucomatous damage.
    Indian Journal of Ophthalmology 09/2014; 62(9):917-22. DOI:10.4103/0301-4738.143927
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: The purpose of this study is to analyze the donor and tissue profile of a community eye bank in Eastern India. Materials and Methods: Eye bank records were analyzed for the period July 2007-June 2011. Variables analyzed included donor demographics (age, gender, and ethnicity), donor cause of death, consent for recovery, death-to-preservation interval, preservation-to-utilization interval, endothelial cell density (ECD), corneal suitability for transplantation, and corneal tissue utilization. Results: During this study period, 743 corneal tissues were retrieved from 373 donors (male:female = 263:110). The mean age of donors was 52 ± 21 years (range: 3-95 years). The most common donor age group was 41-50 and 71-80 years. Most of the donors belonged to one religious faith (99%). The most common causes of death were cardiorespiratory failure (34%) followed by road traffic accident (30%). Majority donors were motivated (n = 320; 86%), and remaining (n = 53; 14%) were voluntary. Most of the consents were given by sons or daughters of the deceased (45%) followed by siblings (18%). Mean death-to-preservation interval was 3.9 ± 1.9 h. Mean preservation-to-utilization interval was 56.0 ± 24.4 h. The mean ECD of donor corneal tissue was 2857 ± 551 cells/mm2 and the median value was 2898 cells/mm2. Of harvested corneas 556 (75%) corneal tissues were utilized. The most common causes of nonutilization were septicemia in donor (n = 56; 30%) and poor quality of tissue (n = 55; 30%). Conclusions: Although, there is significant corneal tissue utilization, there is a need for increased awareness among people in order to augment voluntary donations.
    Indian Journal of Ophthalmology 09/2014; 62(9):935-7. DOI:10.4103/0301-4738.138298
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report a case of large histopathologically proven melanocytoma of the ciliary body in a 15-year-old male, presented with rapid extraocular growth following incisional biopsy with scleral patch graft. We chose brachytherapy with Ruthenium 106 plaque over enucleation as the later was refused by the parents. The initial apical height of the tumor was 14.2 mm on ultrasonography. Two weeks after brachytherapy, the mass regressed to a size of 8.1 mm and 1 year later to 6.7 mm. This is the first case report showing the response of brachytherapy to ciliary body melanocytoma, which results in ocular and visual acuity salvation with considerable decreased in size of the tumor. The authors conclude that brachytherapy is an option in the management of non-resectable melanocytoma of the ciliary body.
    Indian Journal of Ophthalmology 09/2014; 62(9):966-8. DOI:10.4103/0301-4738.143953
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fundus imaging with a fundus camera is an essential part of ophthalmic practice. A mobile phone with its in-built camera and flash can be used to obtain fundus images of reasonable quality. The mobile phone can be used as an indirect ophthalmoscope when coupled with a condensing lens. It can be used as a direct ophthalmoscope after minimal modification, wherein the fundus can be viewed without an intervening lens in young patients with dilated pupils. Employing the ubiquitous mobile phone to obtain fundus images has the potential for mass screening, enables ophthalmologists without a fundus camera to document and share findings, is a tool for telemedicine and is rather inexpensive.
    Indian Journal of Ophthalmology 09/2014; 62(9):960-2. DOI:10.4103/0301-4738.143949
  • Indian Journal of Ophthalmology 09/2014; 62(9):974-5. DOI:10.4103/0301-4738.143971
  • Indian Journal of Ophthalmology 09/2014; 62(9):905-6. DOI:10.4103/0301-4738.143923